NIHR Clinician Scientist, hon Diabetes Consultant, Kings College London
As one of our Clinical Champions, Dr Marietta Stadler will continue to develop the Type 1 Diabetes and Disordered Eating service (T1DE), a pilot clinical service at King’s Health Partners. Furthermore, she will contribute to the type 1 diabetes service development at King’s College Hospital by driving the type 1 diabetes clinical research agenda in collaboration with her colleagues across King’s Health Partners (KHP).
Background
In her current role as NIHR Clinician Scientist, Dr Marietta Stadler runs a 6-year research project to develop a complex intervention for people living with type 1 diabetes and disordered eating, together with a multidisciplinary team of diabetes and mental health care professionals and collaborators across KHP.
Dr Stadler completed her Internal Medicine Specialist and Diabetologist training in Austria, conducted the national insulin pump audit and authored Austria’s first therapy guidelines for insulin pumps. Dr Stadler’s research in the field of type 1 diabetes focuses on the reversibility of pathophysiological features after pancreas transplantation, the epidemiology of late complications, diabetes technology, hypoglycaemia, and has resulted in a higher research degree (Habilitation, venia docendi).
Dr Stadler joined the King’s College London (KCL) Diabetes Research Group as an NIHR Academic Clinical Lecturer in Diabetes in 2013 and was awarded an NIHR Clinician Scientist Fellowship in 2018. She also completed a UK Certificate of Completion of Training in Endocrinology and Diabetes.
It is in her role as honorary Diabetes Consultant at King’s College Hospital London that Dr Stadler contributes to the T1DE service. She has been part of a multidisciplinary team from the inception to the official launch of the NHSE funded Pan-London T1DE pilot service and up until now.
